Your account has not been verified yet. Please click the verification link in the email that has been sent to you.
If you need a new verification email, please click here and a new one will be sent to the email address you provide.

Categories

Aptar Pharma to showcase an industry first

PureHale is a new portable drug delivery device designed for upper respiratory care.

Aptar Pharma will showcase an industry first with its PureHale device – a new portable drug delivery device designed for upper respiratory care - at CPhI Worldwide this year in Madrid.

In addition to PureHale, Aptar Pharma will also reveal:

A range of new connected drug delivery devices designed to help increase dose adherence and improve patient health outcomes

A portfolio of gamma-sterilized drug delivery components to reduce bioburden

Aptar Pharma’s Support Services initiative, a portfolio of stage-specific development packages to help customers in their journey from molecule to market.

“Through a wide range of consulting and services, Aptar Pharma innovates around delivery routes, effective drug delivery, testing and regulatory requirements with partners ranging from small-scale R&D firms to the largest international pharmaceutical companies. We look forward to launching our Support Services initiative at CPhI, and working with our customers to meet their development needs, said Guillaume Brouet, Vice President Analytical, Regulatory and Scientific Affairs at Aptar Pharma.”

Along with showcasing its range of innovative drug delivery devices that address nasal, pulmonary, eye care, injectables and dermal drug delivery routes at Aptar Pharma’s exhibit stand, the company will also be sharing various new solutions in prescription and over-the-counter treatments.